Press Release: Decisiondiagnostics : DECN Engages Second Korean Manufacturing Partner to Raise Its Factory Capacity by Two Million Boxes of ''GEN'' Test Strips Annually

Decision Diagnostics Corp. (OTC PINK: DECN) Decision Diagnostics Corp. is a 16 year olddiabetes focused bio-technology R&D firm, manufacturer, quality plan administrator, FDA registered medical device customer support organization, and exclusive worldwide sales and regulatory process agent for a growing brand of glucose test strips and meters as highly accurate alternatives for legacy diabetic, proprietary, and pet testing glucose test strips. The company’s current portfolio of test strips includes its GenUltimate!, GenChoice!, GenSure!, and GenUltimate! TBG test strips, its Avantage! and Precise! Glucometers, and its PetSure! and GenUltimate! 4Pets testing products for dogs, cats and horses.